1. Home
  2. CODX vs MKZR Comparison

CODX vs MKZR Comparison

Compare CODX & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • MKZR
  • Stock Information
  • Founded
  • CODX 2013
  • MKZR 2012
  • Country
  • CODX United States
  • MKZR United States
  • Employees
  • CODX N/A
  • MKZR N/A
  • Industry
  • CODX Medical/Dental Instruments
  • MKZR
  • Sector
  • CODX Health Care
  • MKZR
  • Exchange
  • CODX Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • CODX 9.8M
  • MKZR 11.4M
  • IPO Year
  • CODX 2017
  • MKZR N/A
  • Fundamental
  • Price
  • CODX $0.28
  • MKZR $0.66
  • Analyst Decision
  • CODX Buy
  • MKZR
  • Analyst Count
  • CODX 2
  • MKZR 0
  • Target Price
  • CODX $5.50
  • MKZR N/A
  • AVG Volume (30 Days)
  • CODX 399.9K
  • MKZR 58.8K
  • Earning Date
  • CODX 08-07-2025
  • MKZR 08-11-2025
  • Dividend Yield
  • CODX N/A
  • MKZR 54.60%
  • EPS Growth
  • CODX N/A
  • MKZR N/A
  • EPS
  • CODX N/A
  • MKZR N/A
  • Revenue
  • CODX $3,497,583.00
  • MKZR $23,037,348.00
  • Revenue This Year
  • CODX N/A
  • MKZR N/A
  • Revenue Next Year
  • CODX $42.11
  • MKZR N/A
  • P/E Ratio
  • CODX N/A
  • MKZR N/A
  • Revenue Growth
  • CODX N/A
  • MKZR 52.64
  • 52 Week Low
  • CODX $0.23
  • MKZR $0.60
  • 52 Week High
  • CODX $2.23
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • CODX 47.58
  • MKZR N/A
  • Support Level
  • CODX $0.27
  • MKZR N/A
  • Resistance Level
  • CODX $0.30
  • MKZR N/A
  • Average True Range (ATR)
  • CODX 0.03
  • MKZR 0.00
  • MACD
  • CODX 0.00
  • MKZR 0.00
  • Stochastic Oscillator
  • CODX 54.00
  • MKZR 0.00

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: